Sage Therapeutics stock plunges 48% after FDA decision on postpartum depression drug

[ad_1] In this photo illustration, the Sage Therapeutics logo of a biopharmaceutical company seen on a smartphone and on a pc screen. Pavlo Gonchar | SOPA Images | Lightrocket |…

Health-care ETFs tend to rise around next week’s annual JPMorgan conference. Here’s what to know

[ad_1] Next week is one of the biggest of the year for health-care investors, and it has historically been a good time to own ETFs that track the industry. The…